Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Biomarker modulation in patients (pts) receiving TRC105 (T) and bevacizumab (B) in a phase Ib clinical trial Proceeding/Conference:Journal of Clinical Oncology | 2014 | ||
Modulation of angiogenic biomarkers in patients receiving high-dose TRC105 Proceeding/Conference:Journal of Clinical Oncology | 2012 | ||
Modulation of angiogenic biomarkers in patients treated on a phase I study of TRC105 (anti-CD105 antibody) monotherapy for advanced solid tumors Proceeding/Conference:Journal of Clinical Oncology | 2011 |